1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Blanco, F.J. Ortiz, A.R. Serrano, L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE J.Biomol.NMR JBNME9 0800 0925-2738 9 347 357 10.1023/A:1018330122908 9255941 1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure. 1997 US Nat.Struct.Biol. NSBIEW 2024 1072-8368 3 874 Different Folding Transition States May Result in the Same Native Structure 1996 UK Nature NATUAS 0006 0028-0836 359 851 Crystal Structure of a Src-Homology 3 (SH3) Domain 1992 10.2210/pdb1aey/pdb pdb_00001aey 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7229.244 ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN 1 man polymer no no MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLD MDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLD A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n chicken sample CYTOSKELETON 9031 BRAIN Gallus gallus 469008 Escherichia coli BL21(DE3) plasmid PET3D database_2 pdbx_database_status pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other 1 0 1997-05-15 1 1 2008-03-26 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name Y BNL 1997-03-02 REL 15 15 NOESY TOCSY COSY HMQC-TOCSY HMQC-NOESY E.COSY 3.5 297 K THE FINAL MODELS WERE ENERGY MINIMIZED IN A SHELL OF WATER MOLECULES USING THE AMBER ALL ATOM FORCE FIELD. VARIABLE TARGET FUNCTION SIMULATED ANNEALING PEARLMAN,CASE,CALDWELL,ROSS,CHEATHAM, FERGUSON,SEIBEL,SINGH,WEINER,KOLLMAN refinement Amber 4.1 structure solution UXNMR structure solution AURELIA structure solution DIANA structure solution Amber 500 Bruker AMX500 n 1 1 A n 2 2 A n 3 3 A n 4 4 A GLY 5 n 5 GLY 5 A LYS 6 n 6 LYS 6 A GLU 7 n 7 GLU 7 A LEU 8 n 8 LEU 8 A VAL 9 n 9 VAL 9 A LEU 10 n 10 LEU 10 A ALA 11 n 11 ALA 11 A LEU 12 n 12 LEU 12 A TYR 13 n 13 TYR 13 A ASP 14 n 14 ASP 14 A TYR 15 n 15 TYR 15 A GLN 16 n 16 GLN 16 A GLU 17 n 17 GLU 17 A LYS 18 n 18 LYS 18 A SER 19 n 19 SER 19 A PRO 20 n 20 PRO 20 A ARG 21 n 21 ARG 21 A GLU 22 n 22 GLU 22 A VAL 23 n 23 VAL 23 A THR 24 n 24 THR 24 A MET 25 n 25 MET 25 A LYS 26 n 26 LYS 26 A LYS 27 n 27 LYS 27 A GLY 28 n 28 GLY 28 A ASP 29 n 29 ASP 29 A ILE 30 n 30 ILE 30 A LEU 31 n 31 LEU 31 A THR 32 n 32 THR 32 A LEU 33 n 33 LEU 33 A LEU 34 n 34 LEU 34 A ASN 35 n 35 ASN 35 A SER 36 n 36 SER 36 A THR 37 n 37 THR 37 A ASN 38 n 38 ASN 38 A LYS 39 n 39 LYS 39 A ASP 40 n 40 ASP 40 A TRP 41 n 41 TRP 41 A TRP 42 n 42 TRP 42 A LYS 43 n 43 LYS 43 A VAL 44 n 44 VAL 44 A GLU 45 n 45 GLU 45 A VAL 46 n 46 VAL 46 A ASN 47 n 47 ASN 47 A ASP 48 n 48 ASP 48 A ARG 49 n 49 ARG 49 A GLN 50 n 50 GLN 50 A GLY 51 n 51 GLY 51 A PHE 52 n 52 PHE 52 A VAL 53 n 53 VAL 53 A PRO 54 n 54 PRO 54 A ALA 55 n 55 ALA 55 A ALA 56 n 56 ALA 56 A TYR 57 n 57 TYR 57 A VAL 58 n 58 VAL 58 A LYS 59 n 59 LYS 59 A LYS 60 n 60 LYS 60 A LEU 61 n 61 LEU 61 A ASP 62 n 62 ASP 62 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O LYS 59 A O LYS 59 A N LEU 10 A N LEU 10 A O GLU 7 A O GLU 7 A N LEU 33 A N LEU 33 A O THR 32 A O THR 32 A N GLU 45 A N GLU 45 A O TRP 42 A O TRP 42 A N VAL 53 A N VAL 53 1 A MET 1 A MET 1 1 Y 1 A ASP 2 A ASP 2 1 Y 1 A GLU 3 A GLU 3 1 Y 1 A THR 4 A THR 4 1 Y 2 A MET 1 A MET 1 1 Y 2 A ASP 2 A ASP 2 1 Y 2 A GLU 3 A GLU 3 1 Y 2 A THR 4 A THR 4 1 Y 3 A MET 1 A MET 1 1 Y 3 A ASP 2 A ASP 2 1 Y 3 A GLU 3 A GLU 3 1 Y 3 A THR 4 A THR 4 1 Y 4 A MET 1 A MET 1 1 Y 4 A ASP 2 A ASP 2 1 Y 4 A GLU 3 A GLU 3 1 Y 4 A THR 4 A THR 4 1 Y 5 A MET 1 A MET 1 1 Y 5 A ASP 2 A ASP 2 1 Y 5 A GLU 3 A GLU 3 1 Y 5 A THR 4 A THR 4 1 Y 6 A MET 1 A MET 1 1 Y 6 A ASP 2 A ASP 2 1 Y 6 A GLU 3 A GLU 3 1 Y 6 A THR 4 A THR 4 1 Y 7 A MET 1 A MET 1 1 Y 7 A ASP 2 A ASP 2 1 Y 7 A GLU 3 A GLU 3 1 Y 7 A THR 4 A THR 4 1 Y 8 A MET 1 A MET 1 1 Y 8 A ASP 2 A ASP 2 1 Y 8 A GLU 3 A GLU 3 1 Y 8 A THR 4 A THR 4 1 Y 9 A MET 1 A MET 1 1 Y 9 A ASP 2 A ASP 2 1 Y 9 A GLU 3 A GLU 3 1 Y 9 A THR 4 A THR 4 1 Y 10 A MET 1 A MET 1 1 Y 10 A ASP 2 A ASP 2 1 Y 10 A GLU 3 A GLU 3 1 Y 10 A THR 4 A THR 4 1 Y 11 A MET 1 A MET 1 1 Y 11 A ASP 2 A ASP 2 1 Y 11 A GLU 3 A GLU 3 1 Y 11 A THR 4 A THR 4 1 Y 12 A MET 1 A MET 1 1 Y 12 A ASP 2 A ASP 2 1 Y 12 A GLU 3 A GLU 3 1 Y 12 A THR 4 A THR 4 1 Y 13 A MET 1 A MET 1 1 Y 13 A ASP 2 A ASP 2 1 Y 13 A GLU 3 A GLU 3 1 Y 13 A THR 4 A THR 4 1 Y 14 A MET 1 A MET 1 1 Y 14 A ASP 2 A ASP 2 1 Y 14 A GLU 3 A GLU 3 1 Y 14 A THR 4 A THR 4 1 Y 15 A MET 1 A MET 1 1 Y 15 A ASP 2 A ASP 2 1 Y 15 A GLU 3 A GLU 3 1 Y 15 A THR 4 A THR 4 1 Y 2 A TYR 13 0.062 SIDE CHAIN 2 A TYR 15 0.090 SIDE CHAIN 2 A ARG 21 0.101 SIDE CHAIN 3 A ARG 21 0.107 SIDE CHAIN 3 A ARG 49 0.076 SIDE CHAIN 4 A TYR 13 0.091 SIDE CHAIN 5 A TYR 15 0.067 SIDE CHAIN 5 A ARG 21 0.114 SIDE CHAIN 7 A TYR 13 0.065 SIDE CHAIN 7 A TYR 15 0.079 SIDE CHAIN 9 A TYR 13 0.070 SIDE CHAIN 10 A TYR 13 0.073 SIDE CHAIN 11 A TYR 13 0.075 SIDE CHAIN 12 A TYR 15 0.093 SIDE CHAIN 12 A ARG 21 0.094 SIDE CHAIN 12 A ARG 49 0.103 SIDE CHAIN 14 A TYR 15 0.109 SIDE CHAIN 15 A TYR 15 0.071 SIDE CHAIN 15 -12.79 2.00 110.40 97.61 A A A CB CA C ASP ASP ASP 48 48 48 N 15 -11.80 1.80 110.60 98.80 A A A N CA CB ARG ARG ARG 49 49 49 N 1 A LYS 6 -76.87 -142.17 1 A LYS 39 75.25 -51.00 1 A ASN 47 60.12 -72.85 1 A ASP 48 -150.93 11.59 2 A LYS 6 -70.92 -125.94 2 A LEU 34 -98.11 -66.53 2 A ASP 40 -130.22 -53.13 2 A ASN 47 65.11 -80.81 3 A LYS 6 -109.75 -153.49 3 A SER 36 -84.30 49.44 3 A ASN 47 61.46 -77.93 4 A GLU 17 -47.14 152.08 4 A ASP 40 -107.74 -65.35 4 A ASN 47 63.93 -76.46 5 A SER 36 -116.61 53.12 5 A ASN 47 65.70 -86.56 6 A LYS 6 58.68 95.34 6 A SER 36 -109.41 43.82 6 A THR 37 -88.73 37.76 6 A ASN 47 62.98 -74.34 6 A ASP 48 -160.18 22.34 7 A LYS 6 -104.67 -152.99 7 A ASN 47 67.49 -71.25 8 A LYS 6 -81.93 -140.14 8 A ASP 40 -152.86 -61.13 8 A ASN 47 67.07 -69.08 8 A ASP 48 -154.04 15.27 9 A THR 37 -61.43 1.69 9 A LYS 39 72.61 -59.89 9 A ASP 40 -90.43 -64.27 9 A ASN 47 61.28 -85.53 10 A LYS 6 59.66 95.73 10 A GLU 17 -39.63 132.67 10 A ASN 47 58.18 -88.71 10 A LEU 61 -93.37 38.77 11 A ASN 47 67.05 -74.99 12 A ASN 47 71.36 -63.16 12 A ASP 48 -153.35 -1.45 12 A GLN 50 -101.10 76.92 13 A LEU 34 -146.37 -32.60 13 A ASP 40 -159.17 -52.05 13 A ASN 47 58.52 -77.11 13 A LEU 61 -96.58 42.25 14 A LYS 6 -158.07 48.25 14 A LEU 34 -79.89 -72.24 14 A ASN 47 64.79 -71.49 14 A ASP 48 -156.38 22.55 15 A LYS 6 -95.02 58.96 15 A LEU 34 -145.48 -48.89 15 A SER 36 -141.58 25.92 15 A ASP 40 -95.47 -63.47 refinement AMBER ALPHA-SPECTRIN SRC HOMOLOGY 3 DOMAIN, SOLUTION NMR, 15 STRUCTURES 1 Y N A ALA 55 A ALA 55 HELX_P A TYR 57 A TYR 57 5 1 3 CYTOSKELETON CYTOSKELETON, CAPPING PROTEIN, CALCIUM-BINDING, DUPLICATION, SH3 DOMAIN SPTA2_CHICK UNP 1 1 P07751 MDPSGVKVLETAEDIQERRQQVLDRYHRFKELSSLRRQKLEDSYRFQFFQRDADELGKWIQEKLQIASDENYKDPSNLQG KLQKHQAFEAEVQANSGAIVKLDETGNQMINEGHFASETIRTRLQELHRLWELLLEKMREKGVKLLQAQKLVQFLRECED VMDWINDKEAIVTSEELGQDLEHVEVLQKKFEEFQTDLAAHEERVNEVNQFAGKLIQEQHPEEELIKSKQDEVNASWQRL KGLAQQRQGKLFGAAEVQRFNRDVDETISWIKEKGQLMASDDFGRDLASVQALLRKHEGLERDLAAFHHKVKALCAEADR LQQSHPINASQIQVKREELIANWEQIRTLAAERHARLNDSYRLQRFLADFRDLTSWVTEMKALINADELANDVAGAEALL DRHQEHKGEIDAHEDSFRSADESGQALLAAGHYASDEVKEKLTILSDERSALLELWELRRQQYEQCMDLQLFYRDTEQVD NWMSKQEAFLLNEDLGDSLDSVEALLKKHEDFEKSLSAQEEKITALDEFATKLIQNNHYAMDDVATRRDALLSRRNALHE RAMKRRAQLADSFHLQQFFRDSDELKSWVNEKMKTATDEAYKDPSNLQGKVQKHQAFEAELSANQSRIDALEKAGQKLID VNHYASDEVAARMNEVISLWKKLLEATELKGIKLREANQQQQFNRNVEDIELWLYEVEGHLASDDYGKDLTSVQNLQKKH ALLEADVAAHQDPIDGITIQARQFQDAGHFDADNIKKKQEALVARYEALKDPMVARKQKLADSLRLQQLFRDIEDEETWI REKEPIAASTNRGKDLIGVQNLLKKHQALQAEIAGHEPRIKAVTQKGNAMVEEGHFAAEDVKIKLNELNQKWDSLKAKAS QRRQDLEDSLQAQQYFADANEAQSWMREKEPIVGSTDYGKDEDSAEALLKKHEALMSDLSAYGSSIQALREQAQSCRQQV APTDDETGKELVLALYDYQEKSPREVTMKKGDILTLLNSTNKDWWKVEVNDRQGFVPAAYVKKLDPAQSASRENLLEEQG SIALRQEQIDNQTLITKEVGSVSLRMKQVEELYHSLLELGEKRKGMLEKSCKKFMLFREANELQQWINEKEAALTNEEVG ADLEQVEVLQKKFDDFQKDLKANESRLKDINKVANDLESEGLMAEEVQAVEHQEVYGMMPRDETDSKTVSPWKSARMMVH TVATFNSIKELNERWRSLQQLAEERSQLLGSADEVQRFHRDADETKEWIEEKNQALNTDNYGHDLASVQALQRNDEGFER DLAALGDKVNSLGETAQRLIQSHPELAEDLQEKCTELNQAWSSLGKRADQRKEKLGDSHDLQRFLSDFRDLMSWINGIRG LVSSDELAKDVTGAEALLERHQEHRTEIDARAGTFQAFEQFGQQLLARGHYASPEIKEKLDILDQERTDLEKAWVQRRMM LDQCLELQLFHRDCEQAENWMAAREAFLNTEDKGDSLDSVEALIKKHEDFDKAINVQEEKIAVLQSFADQLIAADHYAKG VIANRRNEVLDRWRRLKAQMIEKRSKLGESQTLQQFSRDVDEIEAWISEKLQTASDESYKDPTNIQLSKLLSKHQKHQAF EAELHANADRIRGVIEMGNPLIERGACAGSEDAVKARLAALADQWEFLVQKSSEKSQKLKEANKQQNFNTGIKDFDFWLS EVEALLASEDYGKDLASVNNLLKKHQLLEADISAHEDRLKDLNSQADSLMTSSAFDTSQVKDKRETINGRFQRIKSMAAA RRAKLNESHRLHQFFRDMDDEESWIKEKKLLVSSEDYGRDLTGVQNLRKKHKRLEAELAAHEPAIQGVLDTGKKLSDDNT IGKEEIQQRLAQFVDHWKELKQLAAARGQRLEESLEYQQFVANVEEEEAWINEKMTLVASEDYGDTLAAIQGLLKKHEAF ETDFTVHKDRVNDVCANGEDLIKKNNHHVENITAKMKGLKGKVSDLEKAAAQRKAKLDENSAFLQFNWKADVVESWIGEK ENSLKTDDYGRDLSSVQTLLTKQETFDAGLQAFQQEGIANITALKDQLLAAKHIQSKAIEVRHASLMKRWNQLLANSAAR KKKLLEAQEHFRKVEDLFLTFAKKASAFNSWFENAEEDLTDPVRCNSLEEIKALREAHDAFRSSLSSAQADFNQLAELDR QIKSFRVASNPYTWFTMEALEETWRNLQKIIKERELELQKEQRRQEENDKLRQEFAQHANAFHQWIQETRTYLLDGSCMV EESGTLESQLEATKRKHQEIRAMRSQLKKIEDLGAAMEEALILDNKYTEHSTVGLAQQWDQLDQLGMRMQHNLEQQIQAR NTTGVTEEALKEFSMMFKHFDKDKSGRLNHQEFKSCLRSLGYDLPMVEEGEPDPEFESILDTVDPNRDGHVSLQEYMAFM ISRETENVKSSEEIESAFRALSSERKPYVTKEELYQNLTREQADYCISHMKPYMDGKGRELPSAYDYIEFTRSLFVN 965 1025 1AEY 2 62 P07751 A 1 2 62 5 anti-parallel anti-parallel anti-parallel anti-parallel A VAL 58 A VAL 58 A ASP 62 A ASP 62 A GLU 7 A GLU 7 A ALA 11 A ALA 11 A ILE 30 A ILE 30 A ASN 35 A ASN 35 A TRP 41 A TRP 41 A VAL 46 A VAL 46 A ARG 49 A ARG 49 A PRO 54 A PRO 54 1 P 1